Report overview
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging. This report contains market size and forecasts of Clinical Trial Imaging in global, including the following market information:
Global Clinical Trial Imaging Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Clinical Trial Imaging market was valued at US$ 1419.4 million in 2022 and is projected to reach US$ 2277.1 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
We surveyed the Clinical Trial Imaging companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Trial Imaging Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trial Imaging Market Segment Percentages, by Type, 2022 (%)
In-house Imaging Service
Central Imaging Service
Global Clinical Trial Imaging Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trial Imaging Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
Global Clinical Trial Imaging Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Clinical Trial Imaging Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Trial Imaging revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Trial Imaging revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Trial Imaging, market overview.
Chapter 2: Global Clinical Trial Imaging market size in revenue.
Chapter 3: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Trial Imaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
